In Wednesday’s Wall Street session, Abbott Laboratories (NYSE:ABT) shares traded at $137.71, up 0.09% from the previous session.
ABT stock price is now 10.87% away from the 50-day moving average and 20.59% away from the 200-day moving average. The market capitalization of the company currently stands at $238.83B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $130, Oppenheimer recently initiated with Outperform rating for Abbott Laboratories (NYSE: ABT). On September 19, 2024, Piper Sandler recently initiated its ‘Overweight’ rating on the stock quoting a target price of $131, while ‘Edward Jones’ rates the stock as ‘Hold’
In other news, Wainer Andrea F, RETIRED EVP sold 949 shares of the company’s stock on Mar 03 ’25. The stock was sold for $131,123 at an average price of $138.17. Upon completion of the transaction, the RETIRED EVP now directly owns 74,381 shares in the company, valued at $10.24 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 03 ’25, Senior Vice President Shroff Eric sold 562 shares of the business’s stock. A total of $77,652 was realized by selling the stock at an average price of $138.17. This leaves the insider owning 31,970 shares of the company worth $4.4 million. A total of 0.67% of the company’s stock is owned by insiders.
During the past 12 months, Abbott Laboratories has had a low of $99.71 and a high of $141.23. As of last week, the company has a debt-to-equity ratio of 0.32, a current ratio of 1.67, and a quick ratio of 1.23.
The net profit margin was 31.83% and return on equity was 30.96% for ABT. The company reported revenue of $10.97 billion for the quarter, compared to $10.24 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.16 percent.
